GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports
PUBLISHED Sep 13, 2026, 1:07 PM ET
GE HealthCare Technologies is reportedly engaged in late-stage negotiations to acquire radiopharmaceutical developer Sofie Biosciences for approximately $1 billion. According to individuals familiar with the matter cited by financial media reports, a formal agreement could be announced as early as next week. Neither company has officially confirmed the discussions, and corporate representatives declined to comment outside regular business hours. If finalized, the transaction would represent GE HealthCare's second major acquisition following its corporate spin-off from General Electric in 2024. The potential purchase is designed to strengthen GE HealthCare's pharmaceutical diagnostics division by expanding its portfolio of radioactive tracers and chemicals utilized in advanced cancer scans and targeted radiotherapy. Market analysts note that the acquisition would position the medical technology firm more competitively within the rapidly growing global radiopharmaceutical sector, where major healthcare corporations are aggressively consolidating specialized assets to capture rising demand for molecular imaging and precision oncology treatments.
By Sidra | JQJO News
- Articles Published:
- 44
- Right Leaning:
- 2
- Left Leaning:
- 4
- Neutral:
- 38
- Distribution:
- Left 9%, Center 86%, Right 5%
Left: Emphasizes corporate consolidation impacts on healthcare access and pricing. Center: Reports financial terms and strategic corporate expansion details neutrally. Right: Highlights capital investment efficiency and post-spinoff market growth strategies.
Financial Times reported acquisition talks on September 13 2026. https://www.reuters.com/markets/deals/ge-healthcare-talks-over-possible-1-bln-deal-sofie-biosciences-ft-reports-2026-09-13/
Coverage of Story:
From Left
Reports surface of GE HealthCare negotiating billion-dollar deal for Sofie Biosciences
NPR Politico The Independent The AtlanticFrom Center
GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports
Reuters Financial Times Bloomberg Wall Street Journal Fierce Pharma MassDevice MedTech Dive Barron's MarketWatch Zacks Investment Research Seeking Alpha The Street BioWorld Genomeweb Medical Device and Diagnostic Industry Modern Healthcare PitchBook News US News and World Report Associated Press BioCentury MassDevice Insider Diagnostic Imaging Radiology Business DOTmed HealthCare Business News Health Exec Managed Healthcare Executive The Pink Sheet Evaluate Vantage FirstWord Pharma Business Wire Benzinga U.S. News & World Report Money The Hill Axios Forbes Time Newsweek Chicago TribuneFrom Right
Reports indicate GE HealthCare negotiating billion-dollar Sofie Biosciences buyout
The Washington Times Daily Mail
Comments